You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mRNA-4157

Showing 1 - 25 of 785
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Melanoma
  • V940
  • +2 more
  • (no location specified)
Jul 12, 2023

NSCLC Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • V940
  • +2 more
  • (no location specified)
Oct 5, 2023

Solid Tumors Trial in United States (mRNA-4157, Pembrolizumab)

Recruiting
  • Solid Tumors
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +9 more
Sep 20, 2022

Melanoma Trial in Australia, United States (mRNA-4157, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +21 more
Aug 23, 2022

Alzheimer Trial in United States (troriluzole, Placebo oral capsule)

Completed
  • Alzheimer Disease
  • Phoenix, Arizona
  • +43 more
Feb 15, 2022

OCD Trial in United States (BHV-4157, Placebo)

Active, not recruiting
  • Obsessive-Compulsive Disorder
  • Chandler, Arizona
  • +56 more
Feb 15, 2022

SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1273.211
  • +6 more
  • Sacramento, California
  • +22 more
Nov 16, 2022

Seasonal Influenza Trial in United States (mRNA-1011.1, mRNA-1011.2, mRNA-1012.1)

Recruiting
  • Seasonal Influenza
  • mRNA-1011.1
  • +5 more
  • Lakewood, California
  • +21 more
Apr 12, 2023

SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)

Recruiting
  • SARS-CoV-2
  • +2 more
  • mRNA-1010
  • +4 more
  • DeLand, Florida
  • +29 more
Jan 23, 2023

Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)

Recruiting
  • Respiratory Syncytial Virus
  • Human Metapneumovirus
  • mRNA-1345
  • +3 more
  • Andalusia, Alabama
  • +72 more
Feb 15, 2023

Influenza Immunization Trial in Australia (H3 mRNA / LNP Vaccine, Quadrivalent recombinant influenza Vaccine (RIV4))

Recruiting
  • Influenza Immunization
  • H3 mRNA / LNP Vaccine
  • Quadrivalent recombinant influenza Vaccine (RIV4)
  • Herston, Queensland, Australia
  • +3 more
May 1, 2023

Lyme Disease Trial in United States (mRNA-1975, mRNA-1982, Placebo)

Recruiting
  • Lyme Disease
  • mRNA-1975
  • +2 more
  • Milford, Connecticut
  • +19 more
Jul 26, 2023

Norovirus Acute Gastroenteritis Trial in United States (mRNA-1403, mRNA-1405, Placebo)

Not yet recruiting
  • Norovirus Acute Gastroenteritis
  • mRNA-1403
  • +2 more
  • Long Beach, California
  • +14 more
Aug 7, 2023

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Seasonal Influenza Trial in United States (mRNA-1030, mRNA-1020, mRNA-1010)

Completed
  • Seasonal Influenza
  • mRNA-1030
  • +3 more
  • Phoenix, Arizona
  • +14 more
Dec 5, 2022

Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Fluzone HD)

Not yet recruiting
  • Respiratory Syncytial Virus
  • Placebo
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Sep 23, 2023

COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

Not yet recruiting
  • COVID-19
  • mRNA-CR-04 vaccine 10μg
  • +3 more
  • San Diego, California
  • +3 more
Aug 1, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

Heart Transplant Rejection Trial in Helsinki (Cell-free DNA)

Recruiting
  • Heart Transplant Rejection
  • Cell-free DNA
  • Helsinki, Uusimaa, Finland
    Helsinki University Hospital
Oct 2, 2023

SARS-CoV-2 Trial in United States (mRNA-1273, Placebo)

Recruiting
  • SARS-CoV-2
  • mRNA-1273
  • +2 more
  • Banning, California
  • +48 more
Jan 5, 2023

Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)

Not yet recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Birmingham, Alabama
  • +25 more
Nov 10, 2023

SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1073
  • +3 more
  • Hollywood, Florida
  • +13 more
Oct 5, 2022

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Seasonal Influenza Infection Trial in United States (mRNA-1010, Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine)

Not yet recruiting
  • Seasonal Influenza Infection
  • mRNA-1010
  • Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
  • Anniston, Alabama
  • +60 more
Apr 13, 2023

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023